Ospoplus
Board
1 director, no change since January 2026Director (not named in the articles)
since 02-01-2026
term without a fixed end
listed in the 2025 annual accounts, filed on 28-08-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “de meerderheid vormt in het bestuursorgaan, wordt de hoedanigheid van de voorzitter van het bestuursorgaan opgenomen in het register. De…”deed of 20-06-2023
Mandates through the years
3 names, the dashed line is todayBoardEarliermandate already running before its first mentionend not dated
Mandates as a list
- DE WILDER Kenneth
- Director (not named in the articles), since before 31-12-2025
- Osteo Voet
- Director, appointed by deed of 20-06-2023, no longer listed in the 2025 annual accounts
- Sophie Donadi
- Director, appointed by deed of 20-06-2023, no longer listed in the 2025 annual accounts
Control
Founders
OSTEO VOET, SOPHIE DONADI
This company
Ospoplus
Equity -€2,639
Loss €3,729 in 2025
Capital
- Contribution
- €2,400
- Shares
- 240
- Contribution per share
- €10
- Equity per share
- -€10.99 in 2025
- Source
- deed of 20-06-2023
Articles of association
deed of 20-06-2023 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Saturday of June at 14:00
Shareholders
At incorporation
deed of 20-06-2023 ↗
- OSTEO VOET (BE 0790.414.792) 120 shares (50%) · €1,200
- SOPHIE DONADI (BE 0795.427.813) 120 shares (50%) · €1,200